SCHEMBL4428459

SCHEMBL4428459

Cc1cc2cc(N(CC(=O)O)S(=O)(=O)c3cc(Cl)cc(Cl)c3)ccc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.47
KEAP1 Q14145 12/20 0.47
NFE2L2 Q16236 12/20 0.47
SMN1; SMN2 Q16637 1/20 0.44
PPARG P37231 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HCRTR2 O43614 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14089144 0.87 TP53 (0.46) TP53KEAP1NFE2L2SMN1; SMN2ALDH1A1
SCHEMBL13390160 0.86 HCRTR2 (0.37) TP53SMN1; SMN2ALDH1A1HCRTR2
SCHEMBL2842182 0.85 TP53 (0.45) TP53KEAP1NFE2L2SMN1; SMN2ALDH1A1
SCHEMBL2850695 0.82 TP53 (0.44) TP53KEAP1NFE2L2SMN1; SMN2ALDH1A1
SCHEMBL4438874 0.81 SMN1; SMN2 (0.48) TP53KEAP1NFE2L2SMN1; SMN2PPARG
SCHEMBL2845872 0.80 S1PR1 (0.53) TP53KEAP1NFE2L2SMN1; SMN2ALDH1A1
SCHEMBL4433136 0.79 KEAP1 (0.46) TP53KEAP1NFE2L2SMN1; SMN2PPARG
SCHEMBL2843641 0.79 KEAP1 (0.46) TP53KEAP1NFE2L2SMN1; SMN2PPARG
SCHEMBL2841946 0.78 OXTR (0.48) TP53KEAP1NFE2L2ALDH1A1L3MBTL1
SCHEMBL3305698 0.77 PTGS2 (0.38) SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121600-B1 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INT (DE) 2012-07-18 EP disclosed
EP-2121600-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2009-11-25 EP disclosed
WO-2008099000-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-08-21 WO disclosed